Silverwood Partners
  • About Us
    • Overview
    • Why Silverwood?
    • Careers
    • Our Location
    • Connect With Us
  • Insights & Analysis
    • Newsletters
    • Intelligence Briefs
    • Events
    • Connect With Us
  • Team
    • All Team
    • Technology
    • Consumer
    • Healthcare
  • Industry Experience
    • Technology
    • Consumer
    • Healthcare
    • Connect With Us
  • Services
    • Mergers & Acquisitions
    • Private Placements
    • Connect With Us
  • Transactions
    • All Transactions
    • Technology
    • Consumer
    • Healthcare
    • Connect With Us
Select Page
Healthcare Private Placement and M&A Transactions Review Week Ending September 29, 2024

Healthcare Private Placement and M&A Transactions Review Week Ending September 29, 2024

by Jonathan Hodson-Walker | Oct 3, 2024 | Healthcare

trategy | Financing Transactions Private Placement / Financing Transactions EGYM: The company raised an estimated $200 million of Series G venture funding led by L Catterton with participation from Meritech Capital Partners on September 24, 2024, putting the...
Healthcare Private Placement and M&A Transactions Review Week Ending September 22, 2024

Healthcare Private Placement and M&A Transactions Review Week Ending September 22, 2024

by Jonathan Hodson-Walker | Sep 25, 2024 | Healthcare

Strategy | Financing Transactions Private Placement / Financing Transactions Nura Bio: The company raised $141 million of Series A venture funding in a deal led by The Column Group on September 17, 2024, putting the company’s pre-money valuation at $35 million....
Healthcare Private Placement and M&A Transactions Review Week Ending September 15, 2024

Healthcare Private Placement and M&A Transactions Review Week Ending September 15, 2024

by Jonathan Hodson-Walker | Sep 18, 2024 | Healthcare

Strategy | Financing Transactions Private Placement / Financing Transactions Pantera: The company raised EUR 134 million of Series A venture funding on September 11, 2024, putting the company’s pre-money valuation at EUR 179.8 million. The company is an operator...
Healthcare Private Placement and M&A Transactions Review Week Ending September 8, 2024

Healthcare Private Placement and M&A Transactions Review Week Ending September 8, 2024

by Jonathan Hodson-Walker | Sep 12, 2024 | Healthcare

Strategy | Financing Transactions Private Placement / Financing Transactions Egenesis: The company raised $191 million of Series D venture funding in a deal led by Lux Capital on September 4, 2024. Fresenius Medical Care Ventures, Leaps by Bayer, DaVita, Eisai...
Healthcare Private Placement and M&A Transactions Review Week Ending September 1, 2024

Healthcare Private Placement and M&A Transactions Review Week Ending September 1, 2024

by Jonathan Hodson-Walker | Sep 5, 2024 | Healthcare

Strategy | Financing Transactions Private Placement / Financing Transactions Navigator Medicines: The company raised $100 million of Series A venture funding in a deal led by RA Capital Management and Forbion on August 27, 2024, putting the company’s pre-money...
Healthcare Private Placement and M&A Transactions Review Week Ending August 25, 2024

Healthcare Private Placement and M&A Transactions Review Week Ending August 25, 2024

by Jonathan Hodson-Walker | Aug 29, 2024 | Healthcare

Strategy | Financing Transactions Private Placement / Financing Transactions Borealis Biosciences: The company raised $150 million of Series A venture funding from Novartis and Versant Ventures on August 22, 2024. The company is an operator of a discovery-stage...
« Older Entries
Next Entries »

Search

Recent Posts

  • Technology Private Placement and M&A Transactions Review Week Ending May 4, 2025
  • Consumer Private Placement and M&A Transactions Review Week Ending May 4, 2025
  • Healthcare Private Placement and M&A Transactions Review Week Ending May 4, 2025
  • Technology Private Placement and M&A Transactions Review Week Ending April 27, 2025
  • Consumer Private Placement and M&A Transactions Review Week Ending April 27, 2025

Categories

Archives